Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne E Lapi

Showing results (1-10 of 172) with videos related to

Pageof 18
Sort By:
Molecular Imaging|September 22, 2020
Peptide Based Imaging Agents for HER2 Imaging in OncologyMaxwell Ducharme, Suzanne E Lapi
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Titanium-45 (<sup>45</sup>Ti) Radiochemistry and Applications in Molecular ImagingShefali Saini, Suzanne E Lapi
Journal of Labelled Compounds & Radiopharmaceuticals|October 14, 2021
Meet the advisors - Suzy LapiSuzanne E Lapi, Paul Trevorrow
Cancers|April 30, 2021
Positron Emission Tomography Imaging of Macrophages in CancerCandace C Parker, Suzanne E Lapi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2018
Production and Use of the First-Row Transition Metal PET Radionuclides <sup>43,44</sup>Sc, <sup>52</sup>Mn, and <sup>45</sup>TiIvis F Chaple, Suzanne E Lapi
Future Medicinal Chemistry|April 30, 2011
The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86Oluwatayo F Ikotun, Suzanne E Lapi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2013
Designing the magic bullet? The advancement of immuno-PET into clinical useBrian D Wright, Suzanne E Lapi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2015
Pretargeted Immuno-PET: Overcoming Limitations of Space and TimeBernadette V Marquez, Suzanne E Lapi
Nuclear Medicine and Biology|January 21, 2012
A historical perspective on the specific activity of radiopharmaceuticals: what have we learned in the 35 years of the ISRC?Suzanne E Lapi, Michael J Welch
The Lancet. Oncology|March 7, 2021
Global access to medical imaging and nuclear medicineSuzanne E Lapi, Jonathan E McConathy
Pageof 18

Showing results (1-10 of 172) with videos related to

Sort By:
Pageof 18
Molecular Imaging|September 22, 2020
Peptide Based Imaging Agents for HER2 Imaging in OncologyMaxwell Ducharme, Suzanne E Lapi
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Titanium-45 (<sup>45</sup>Ti) Radiochemistry and Applications in Molecular ImagingShefali Saini, Suzanne E Lapi
Journal of Labelled Compounds & Radiopharmaceuticals|October 14, 2021
Meet the advisors - Suzy LapiSuzanne E Lapi, Paul Trevorrow
Cancers|April 30, 2021
Positron Emission Tomography Imaging of Macrophages in CancerCandace C Parker, Suzanne E Lapi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 29, 2018
Production and Use of the First-Row Transition Metal PET Radionuclides <sup>43,44</sup>Sc, <sup>52</sup>Mn, and <sup>45</sup>TiIvis F Chaple, Suzanne E Lapi
Future Medicinal Chemistry|April 30, 2011
The rise of metal radionuclides in medical imaging: copper-64, zirconium-89 and yttrium-86Oluwatayo F Ikotun, Suzanne E Lapi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2013
Designing the magic bullet? The advancement of immuno-PET into clinical useBrian D Wright, Suzanne E Lapi
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 15, 2015
Pretargeted Immuno-PET: Overcoming Limitations of Space and TimeBernadette V Marquez, Suzanne E Lapi
Nuclear Medicine and Biology|January 21, 2012
A historical perspective on the specific activity of radiopharmaceuticals: what have we learned in the 35 years of the ISRC?Suzanne E Lapi, Michael J Welch
The Lancet. Oncology|March 7, 2021
Global access to medical imaging and nuclear medicineSuzanne E Lapi, Jonathan E McConathy
Pageof 18